Technical Analysis for ATOWW - Atossa Genetics Inc. - Warrants [24/05/2021]

Grade Last Price % Change Price Change
grade B 1.34 282.86% 0.9900
ATOWW closed up 282.86 percent on Tuesday, July 2, 2019, on 10 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Up Up
See historical ATOWW trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
180 Bullish Setup Bullish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Outside Day Range Expansion 282.86%
Wide Bands Range Expansion 282.86%
Below Lower BB Weakness 282.86%
Down 3 Days in a Row Weakness 282.86%

Older signals for ATOWW ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Atossa Genetics Inc. a clinical-stage pharmaceutical company, focuses on the development and sale of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions in the United States. The company is conducting a Phase 2 clinical study using microcatheters to deliver fulvestrant as a potential treatment of ductal carcinoma in situ and breast cancer; and a pharmaceutical program under development is Endoxifen, an active metabolite of tamoxifen, as well as treatment for breast density and other breast health conditions. It offers ForeCYTE Breast Aspirator and FullCYTE Breast Aspirator, which collects specimens of nipple aspirate fluid (NAF)for cytological testing at a laboratory; and a transport kit to assist with the packaging and transport of NAF samples to a laboratory, as well as manufactures and sells various medical devices primarily consisting of tools to assist breast surgeons. Atossa Genetics Inc. was founded in 2009 and is headquartered in Seattle, Washington.
RTT Pharmaceutical Drugs Medical Devices Breast Cancer Endocrine System Hormones Astrazeneca Treatment Of Breast Cancer
Is ATOWW a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 3.1
52 Week Low 0.01
Average Volume 27,987
200-Day Moving Average 0.0
50-Day Moving Average 0.6871
20-Day Moving Average 0.987
10-Day Moving Average 0.854
Average True Range 0.4676
ADX 25.59
+DI 26.5775
-DI 31.5004
Chandelier Exit (Long, 3 ATRs ) 0.6972
Chandelier Exit (Short, 3 ATRs ) 1.4128
Upper Bollinger Band 1.564
Lower Bollinger Band 0.41
Percent B (%b) 0.81
BandWidth 116.919959
MACD Line 0.0057
MACD Signal Line 0.0419
MACD Histogram -0.0362
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.9400
Resistance 3 (R3) 1.8767 1.6133 1.8400
Resistance 2 (R2) 1.6133 1.4605 1.6450 1.8066
Resistance 1 (R1) 1.4767 1.3661 1.5450 1.5400 1.7733
Pivot Point 1.2133 1.2133 1.2475 1.2450 1.2133
Support 1 (S1) 1.0767 1.0605 1.1450 1.1400 0.9067
Support 2 (S2) 0.8133 0.9661 0.8450 0.8734
Support 3 (S3) 0.6767 0.8133 0.8400
Support 4 (S4) 0.7400